These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29766614)

  • 1. Noninferiority trials in oral medicine.
    Antunes JLF; Domaneschi C; Lemos CA
    Oral Dis; 2019 Mar; 25(2):357-362. PubMed ID: 29766614
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninferiority Trials in Interventional Cardiology.
    Kolte D; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28790166
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodological quality of oncology noninferiority clinical trials.
    Wayant C; Ross A; Vassar M
    Crit Rev Oncol Hematol; 2020 May; 149():102938. PubMed ID: 32172223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority studies: Not inherently unethical.
    McCarren M; Semla TP
    Am J Health Syst Pharm; 2018 Jun; 75(12):915-918. PubMed ID: 29880527
    [No Abstract]   [Full Text] [Related]  

  • 5. Are noninferiority studies ethically inferior?
    Graber MA; Ely J; Faine BA
    Am J Health Syst Pharm; 2018 Jun; 75(12):911-914. PubMed ID: 29880526
    [No Abstract]   [Full Text] [Related]  

  • 6. Superiority Versus Noninferiority.
    Pfeffer G; Pinzur MS; Adams W
    Foot Ankle Int; 2020 May; 41(5):624-625. PubMed ID: 31707859
    [No Abstract]   [Full Text] [Related]  

  • 7. The inferiority of noninferiority trials.
    Udayasiri DK; Skandarajah A; Hayes IP
    ANZ J Surg; 2020 Mar; 90(3):203-205. PubMed ID: 32147920
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing noninferiority: Evaluating efficacy of a new treatment without complete data.
    Gao P; Odem-Davis K
    Pharm Stat; 2019 Oct; 18(5):546-554. PubMed ID: 30977258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.
    Lesaffre E
    Semin Liver Dis; 2018 May; 38(2):97-102. PubMed ID: 29871016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials.
    Budde H; Amatriain-Fernández S; Trautmann S
    JAMA Psychiatry; 2023 May; 80(5):522-523. PubMed ID: 36920358
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials-Reply.
    Hoge EA; Bui E; Simon NM
    JAMA Psychiatry; 2023 May; 80(5):523. PubMed ID: 36920354
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninferiority Clinical Trials: Overview for the Clinical Cardiologist.
    Murphy SA; Bellavia A
    Circulation; 2024 Sep; 150(11):823-825. PubMed ID: 39250539
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced-Frequency Endocrine Therapy and Challenges of Noninferiority Study Designs.
    Fabian CJ; Mudaranthakam DP
    JAMA Oncol; 2023 May; 9(5):672-674. PubMed ID: 36951870
    [No Abstract]   [Full Text] [Related]  

  • 14. The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.
    Jatoi I; Gail MH
    JAMA Oncol; 2020 Mar; 6(3):420-424. PubMed ID: 31830235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Users' guide to the surgical literature: how to assess a noninferiority trial.
    Thoma A; Farrokhyar F; Waltho D; Braga LH; Sprague S; Goldsmith CH
    Can J Surg; 2017 Dec; 60(6):426-432. PubMed ID: 29173262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriate.
    Althunian TA; de Boer A; Groenwold RHH; Klungel OH
    J Clin Epidemiol; 2018 Dec; 104():15-23. PubMed ID: 30009941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some issues for the evaluation of noninferiority trials.
    Xie X; Wang M; Ng V; Sikich N
    J Comp Eff Res; 2018 Sep; 7(9):835-843. PubMed ID: 30192159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninferiority studies with multiple reference treatments.
    Li-Ching H; Miin-Jye W; Hung CS; Shing KK
    Stat Methods Med Res; 2017 Jun; 26(3):1295-1307. PubMed ID: 25792542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group-sequential three-arm noninferiority clinical trial designs.
    Ochiai T; Hamasaki T; Evans SR; Asakura K; Ohno Y
    J Biopharm Stat; 2017; 27(1):1-24. PubMed ID: 26892481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninferiority randomised trials in ophthalmology.
    Kim K; Zeraatkar D; Pitre TS; Phillips M; Wykoff CC; Garg SJ; Guymer RH; Thabane L; Bhandari M; Chaudhary V;
    Eye (Lond); 2023 Oct; 37(15):3059-3060. PubMed ID: 36869135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.